Work

Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials

Year: 2015
Type: review
Abstract: Recently, a number of phage therapy phase I and II safety trials have been concluded, showing no notable safety concerns associated with the use of phage. Though hurdles for efficient treatment remain, these trials hold promise for future phase III clinical trials. Interestingly, most phage formulations used in these clinical trials are straightforward phage suspensions, and not much research has focused on the processing of phage cocktails in specific pharmaceutical dosage forms. Additional research on formulation strategies and the stability of phage-based drugs will be of key importance, especially with phage therapy advancing toward phase III clinical trials.
Language: English
Subfield: Virology
Open Access status: bronze
OpenAlex ID: W2117604880
FWCI: 1.551
Cites: 109
Cited by: 199
Related to: 10